Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case Series

Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case Series

Introduction: Limited data are available on the course of Coronavirus disease 2019 (COVID-19) in people with Multiple Sclerosis (MS). More real-world data are needed to help the MS community to manage MS treatment properly. In particular, it is important to understand the impact of immunosuppressive...

Full description

Bibliographic Details
Main Authors: Stefania F. De Mercanti, Marco Vercellino, Chiara Bosa, Anastasia Alteno, Valentina Schillaci, Marinella Clerico, Paola Cavalla
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Neurology
Subjects:
multiple sclerosis
ocrelizumab
COVID-19
SARS-CoV-2
disease-modifying treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.691616/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2021.691616/full

Similar Items